Search results for "Highlights"
Researchers identify 5 subgroups of patients with type 2 diabetes
The Swedish study grouped patients based on six key variables, including presence of glutamate decarboxylase antibodies, age at diagnosis, body mass index, HbA1c level, and estimates of beta-cell function and insulin resistance.
https://diabetes.acponline.org/archives/2018/03/09/1.htm
9 Mar 2018
Incretin-based drugs not associated with higher risk of pancreatitis in large, population-based study
The findings of this study should provide some reassurance to patients treated with incretin-based drugs, according to the authors.
https://diabetes.acponline.org/archives/2016/08/12/2.htm
12 Aug 2016
Commonly used blood glucose monitors may not always be accurate, study indicates
Researchers assessed the accuracy of 18 FDA-approved blood glucose monitoring systems, representing approximately 90% of those available in the U.S. from 2013 to 2015.
https://diabetes.acponline.org/archives/2018/07/13/1.htm
13 Jul 2018
Socioeconomic status appears linked to mortality in patients with type 2 diabetes
The study looked at data from the Sweden National Diabetes Register to determine what patient characteristics were related to all-cause mortality or death from cardiovascular-, diabetes-, or cancer-related causes.
https://diabetes.acponline.org/archives/2016/07/15/3.htm
15 Jul 2016
Intensive glycemic treatment may be common, doubles risk of hypoglycemia
Intensive treatment was defined as use of more glucose-lowering medications than recommended by practice guidelines and was found in 18.7% of clinically complex Medicare patients.
https://diabetes.acponline.org/archives/2016/06/10/2.htm
10 Jun 2016
Mortality rates, deaths from vascular causes among U.S. adults with diabetes have decreased over time
Between 1988 to 1994 and 2010 to 2015, all-cause mortality rates among adults with diabetes dropped most in men and those ages 65 to 74 years, and there was no decline in death rates among those ages 20 to 44 years.
https://diabetes.acponline.org/archives/2018/06/08/1.htm
8 Jun 2018
Thiazolidinedione add-ons associated with less CV risk, study finds
The U.K.-based retrospective cohort study used a database that linked national hospitalization and mortality data for people who were prescribed second-line regimens after metformin.
https://diabetes.acponline.org/archives/2016/07/15/2.htm
15 Jul 2016
Excess mortality examined in older patients with diabetes
Excess mortality associated with diabetes was highest in patients younger than age 75 who had had diabetes for a longer time period, with the relative hazard highest in women, a study found.
https://diabetes.acponline.org/archives/2016/06/10/3.htm
10 Jun 2016
Adding DPP-4s to sulfonylureas may increase hypoglycemia risk
The review of 10 randomized controlled trials found 1 excess case of hypoglycemia for every 17 patients in the first 6 months of combined treatment.
https://diabetes.acponline.org/archives/2016/05/13/2.htm
13 May 2016
Second-line therapies for type 2 diabetes may offer similar glycemic control
The only significant difference found by the meta-analysis was a small increase in myocardial infarction and eye disorders with sulfonylureas compared with dipeptidyl peptidase-4 inhibitors.
https://diabetes.acponline.org/archives/2018/09/14/1.htm
14 Sep 2018